Cervical Cancer Screening in 2022: Why Co-Testing is Essential for Patient-Centered Care

January 12, 2022

On Jan. 26, ASCP CEO Blair Holladay, PhD, MASCP, SCT(ASCP)CM, will moderate a free roundtable discussion on cervical cancer screening strategy in the U.S. Dr. Holladay and a multi-disciplinary panel of experts featuring cytopathologists and Ob/Gyns will use patient case-based reviews to address the following topics:

• Proven benefits of co-testing (Pap + hrHPV) for detection of pre-cancers and cancers;
• Impact of new screening guidelines on women’s health and patient care;
• Strategies for reducing cervical cancer in populations that experience healthcare inequities; and, 
• Role of healthcare professionals, pathology and laboratory medicine in patient support and education.

To learn more or register now, click here.
 
To read more articles from this issue of ePolicy, click here. To learn more about ePolicy News and access past newsletters and articles, click here.

For more information regarding ASCP's advocacy initiatives and policy positions, please contact ASCP's Center for Public Policy at (202) 408-1110.

sponsors_hologic
ASCP ePolicy News is supported by an unrestricted grant from Hologic.

ADVERTISEMENT